GeneDx Holdings Corp.
WGS · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$7,635 | $10,809 | -$6,529 | $5,438 |
| Dep. & Amort. | $6,474 | $6,191 | $5,678 | -$5,608 |
| Deferred Tax | $246 | -$245 | $447 | -$24 |
| Stock-Based Comp. | $10,586 | $7,813 | $3,983 | $2,845 |
| Change in WC | -$2,871 | -$16,339 | $3,351 | -$7,761 |
| Other Non-Cash | $8,967 | $2,191 | $3,252 | $1,927 |
| Operating Cash Flow | $15,767 | $10,420 | $10,182 | -$3,183 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$6,172 | -$2,369 | -$6,129 | -$3,050 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$5,765 | -$13,561 | -$17,209 | -$13,577 |
| Inv. Sales/Matur. | $7,250 | $12,775 | $13,930 | $16,108 |
| Other Inv. Act. | $0 | -$33,195 | $0 | $0 |
| Investing Cash Flow | -$4,687 | -$36,350 | -$9,408 | -$519 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$1,216 | -$853 | -$911 | $1,697 |
| Stock Issued | $11,802 | $1,134 | $14,629 | $31,907 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $182 | $65 | $0 | $43,939 |
| Financing Cash Flow | $10,768 | $346 | $13,718 | $31,023 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $21,848 | -$25,584 | $14,492 | $27,321 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $75,110 | $100,694 | $86,202 | $58,881 |
| End Cash | $96,958 | $75,110 | $100,694 | $86,202 |
| Free Cash Flow | $9,595 | $8,051 | $4,053 | -$6,233 |